Listen for Patients on a "Flozin" Talking About Sudden Illness

July 2015

See updated FDA information (December 2015) concerning SGLT2 inhibitors (Flozins) and ketoacidosis/urinary tract infections.

You'll see new warnings about whether "flozins" (Invokana, Farxiga, Jardiance, etc) increase the risk of elevated "ketones" in the blood.

Having high ketones in the blood can lead to coma and death.

Ketoacidosis is most commonly seen in patients with VERY high blood sugar. In these cases, there isn't enough insulin to move all the sugar into the cells to fuel the body's needs...so the body breaks down fat instead, resulting in elevated ketones in the blood.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote